Healthcare - Medical - Devices - NASDAQ - US
$ 6.34
-1.71 %
$ 250 M
Market Cap
-4.4
P/E
BALANCE SHEET
178 M
ASSETS
59.5 M
LIABILITIES
118 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Pulmonx Corporation
| Current Assets | 150 M |
| Cash & Short-Term Investments | 117 M |
| Receivables | 12.1 M |
| Other Current Assets | 21.2 M |
| Non-Current Assets | 27.4 M |
| Long-Term Investments | 14.4 M |
| PP&E | 7.43 M |
| Other Non-Current Assets | 5.54 M |
| Current Liabilities | 23.2 M |
| Accounts Payable | 1.5 M |
| Short-Term Debt | 8.3 M |
| Other Current Liabilities | 13.4 M |
| Non-Current Liabilities | 36.3 M |
| Long-Term Debt | 36.2 M |
| Other Non-Current Liabilities | 114 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 83.5 | 101.7 | 148.5 | 231.6 | 14.8 | 4.1 |
| Short Term Investments | 33.6 | 39.4 | 31.6 | 0 | 13.6 | 0 |
| Receivables | 12.1 | 8.7 | 6.6 | 4.2 | 6.0 | 3.4 |
| Inventory | 16.7 | 14.6 | 16.3 | 10.7 | 5.6 | 3.3 |
| Other Current Assets | 3.6 | 4.0 | 4.8 | 3.1 | 1.1 | 0.4 |
| Total Current Assets | 150.4 | 169.0 | 208.0 | 250.0 | 41.1 | 11.3 |
| PP&E | 7.4 | 10.5 | 12.9 | 10.4 | 7.5 | 0.4 |
| Intangible Assets | 31 K | 0.2 | 0.3 | 0.4 | 0.5 | 0.6 |
| Goodwill | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 |
| Long Term Investments | 14.4 | 5.9 | 10.9 | 0 | 0 | 0 |
| Other Long Term Assets | 3.2 | 5.4 | 0.3 | 0.5 | 2.1 | 0.3 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 177.8 | 193.7 | 235.2 | 263.7 | 53.5 | 15.0 |
| LIABILITIES | ||||||
| Accounts Payable | 1.5 | 1.8 | 1.6 | 1.5 | 2.7 | 1.3 |
| Short Term Debt | 8.3 | 6.5 | 2.3 | 4.5 | 0.4 | 0 |
| Other Current Liabilities | 13.2 | 10.0 | 13.4 | 6.4 | 9.9 | 5.9 |
| Total Current Liabilities | 23.2 | 18.5 | 17.6 | 12.5 | 14.2 | 8.1 |
| Long Term Debt | 36.2 | 24.9 | 24.2 | 25.0 | 226.7 | 33.6 |
| Deferred Tax Income | 0.1 | 94 K | 37 K | 62 K | 43 K | 48 K |
| Other Liabilities | 0 | (3.8) | 0.2 | 0 | 0 | 140.6 |
| Total Liabilities | 59.5 | 39.7 | 41.9 | 37.6 | 240.9 | 182.3 |
| EQUITY | ||||||
| Common Stock | 39 K | 38 K | 37 K | 36 K | 19 K | 17 K |
| Retained Earnings | (411.2) | (350.3) | (291.4) | (242.7) | (210.5) | (189.8) |
| Other Accumulative Comprehensive Income/Loss | 2.6 | 1.6 | 1.7 | 1.7 | 1.4 | 1.3 |
| Total Equity | 118.3 | 154.0 | 193.2 | 226.1 | (187.4) | (167.3) |
| Total Liabilities and Equity | 177.8 | 193.7 | 235.2 | 263.7 | 53.5 | 15.0 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 38.0 | 37.1 | 36.1 | 35.7 | 35.4 | 20.7 |